Przemyslaw W. Twardowski, MD

Accepting New Patients
Offers Video Visits
2121 Santa Monica Boulevard
Santa Monica, CA 90404
2285.1 miles away
Medical Groups & Affiliations
Providence Specialty Medical Group
Speaks: English, Russian and Polish
map

Providence Specialty Medical Group

2121 Santa Monica Boulevard, Santa Monica, CA 90404

Are you covered?

Check to see if your insurance is covered by this provider.

About Przemyslaw W. Twardowski

Przemyslaw Twardowski M.D., has been selected as one of America’s Top Doctors multiple times and with patients leaving reviews like this it comes as no surprise: “Dr. T is an awesome doctor! He has been my doctor for the past 4 almost 5 years now. He is very thorough and has a great bedside manner, very compassionate. ” Currently he is a Professor of Medical Oncology and practicing oncologist at the Department of Genitourinary Oncology at the Saint John’s Cancer Institute at Providence Saint John’s Health.

Both of Dr. Twardowski‘ s parents and his grandfather were physicians so there was an element of family tradition involved in his choice to pursue medicine. His father is most responsible for instilling great interest and excitement in his pursuit of excellence in science and medicine. What gives Dr. Twardowski the greatest satisfaction in his practice is seeing his sick patients get better and enjoy their lives again.

He has vast experience in the management of genitourinary malignancies including prostate, bladder, kidney and testicular cancers. Over the last twenty years he was a principal investigator and contributor to multiple clinical trials that expanded treatment options for patients with cancers of genitourinary tract.

Dr. Twardowski is a board certified medical oncologist and is a member of the American Society of Clinical Oncology. He has practiced medicine in the state of California for over twenty years. His medical philosophy is to provide passionate, state of the art cancer treatment always considering each patient’s unique circumstances and values.

In addition to his state of the art cancer care, he is a professor of medical oncology and has years of experience in oncology and therapeutics research. He has been awarded multiple grants and received numerous awards both as a student and then as an oncologist and researcher. He is a graduate of the University of Missouri and was Chief Resident in the Department of Internal Medicine at Northwestern University where he did his internship, residency and fellowship. He then spent nineteen years at City of Hope National Medical Center. He started as a staff physician, progressed to Clinical Professor of Medical Oncology and is now bringing his expertise to Providence Saint John’s Health.

Internship

McGaw Medical Center of Northwestern University, Evanston, IL

Residency

McGaw Medical Center of Northwestern University, Evanston, IL

Fellowship

McGaw Medical Center of Northwestern University, Evanston, IL

Medical School

University of Missouri-Columbia School of Medicine, Columbia, MO

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
Providence Specialty Medical Group
2121 Santa Monica Boulevard
Santa Monica, CA 90404

Medical Groups & Affiliations
Providence Specialty Medical Group

Affiliated Locations
Saint John’s Health Center Cancer Clinic – Santa Monica
Providence Saint John's Health Center

When not at the office you can find Dr. Twardowski enjoying a wide array of hobbies. Flying a single engine plane, swimming, playing the piano and just being at home are his favorite pastimes.

Clinical Interests

  • Abdominal Cancer
  • Abdominal Cancer Chemotherapy
  • Abnormal Urine Cytology
  • Adenocarcinoma Of The Bladder
  • Adjuvant Chemotherapy
  • Adjuvant Chemotherapy
  • Adolescent And Young Adult Cancer (Aya)
  • Adult T Cell Lymphoma
  • Advanced Malignancies
  • Aids Related Malignancies
  • Alk Negative Anaplastic Large Cell Lymphoma
  • Alveolar Soft Part Sarcoma
  • Anal Cancer Chemotherapy
  • Anaplastic Cancer Of Thyroid
  • Anaplastic Meningioma
  • Androgen Deprivation Therapy
  • Anorectal Cancer Chemotherapy
  • Appendiceal Cancer Chemotherapy
  • Aranesp Injection
  • Atypical Meningioma
  • Autoimmune Cytopenia
  • Autoimmune Lymphoproliferative Syndrome (Alps)
  • Biliary Tract Cancer Chemotherapy
  • Bladder Cancer Chemotherapy
  • Bladder Cancer Genomics
  • Blood Cancer Chemotherapy
  • Blood Transfusion Therapy
  • Bone Marrow Fibrosis
  • Brain Cancer Chemotherapy
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Bronchus Associated Lymphoid Tissue Lymphoma
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Immunotherapy
  • Cancer Of The Joints
  • Cancer Of The Muscles
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Cognitive Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Sexual Concerns
  • Cancer Related Stress Disorder
  • Cancer Risk
  • Cancer Risk Assessment
  • Cancer Survivor
  • Cancer Vaccine
  • Carcinoma Of Unknown Primary
  • Cervical Cancer
  • Cervical Cancer Chemotherapy
  • Cervical Cancer Genomics
  • Chemoradiation
  • Chemotherapy Toxicity
  • Chronic Neutrophilic Leukemia
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer Chemotherapy
  • Colon Cancer Genomics
  • Colorectal Cancer Chemotherapy
  • Crizotinib
  • Denys Drash Syndrome (Dds)
  • Developmental Therapeutics Management
  • Diaphragm Cancer
  • Diffuse Intrinsic Pontine Glioma (Dipg)
  • Ductal Carcinoma In Situ (Dcis)
  • Ear Canal Cancer
  • Ear Cancer
  • Egfr Mutation
  • Egfr Translocation
  • Electrolyte Abnormalities In Cancer Patients
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Endometrial Cancer Chemotherapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erbb2 Mutation
  • Erlotinib
  • Erythrocytosis
  • Esophageal Cancer
  • Esophageal Cancer Chemotherapy
  • Extranodal Nk T Cell Lymphoma
  • Eye Cancer
  • Eye Cancer Chemotherapy
  • Eyelid Cancer
  • Eyelid Cancer Chemotherapy
  • Face Cancer
  • Fallopian Tube Cancer Chemotherapy
  • Familial Renal Cell Carcinoma
  • Fibrous Meningioma
  • Flt3 Mutation
  • Gallbladder Cancer
  • Gallbladder Cancer Chemotherapy
  • Gallbladder Cancer Genomics
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (Gi) Cancer
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gleason Score
  • Glottis Cancer
  • Gynecologic (Gyn) Cancer
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Chemotherapy
  • Head And Neck Cancer Genomics
  • Head And Neck Tumors
  • Head Cancer
  • Hemolytic Uremic Syndrome
  • Hepatic Artery Infusion Pump
  • Hepatic Artery Infusion Pump Placement
  • Hereditary Kidney Cancer
  • Hereditary Papillary Renal Cell Cancer
  • Hereditary Retinoblastoma
  • High Risk Cancer Surveillance
  • Histiocytic Sarcoma
  • Histiocytoma
  • Hormone Based Chemotherapy
  • Human Epidural Growth Factor 2 Mutation
  • Human Papillomavirus (Hpv) Related Penile Cancer
  • Human T-Cell Lymphotropic Virus Type 1
  • Human T-Cell Lymphotropic Virus Type 2
  • Hyperthermic Intraperitoneal Chemotherapy (Hipec)
  • Hypopharyngeal Cancer Chemotherapy
  • Idh 1 Mutation
  • Immature Teratoma
  • Immunoassay For Tumor Antigen Ca 125
  • Immunoassay For Tumor Antigen Ca 15-3 And Ca 27-29
  • Infantile Myofibroblastic Tumors
  • Intrapleural Chemotherapy
  • Intravesical Chemotherapy
  • Intravesical Therapy
  • Kidney Cancer
  • Lacrimal Gland Cancer
  • Large Cell Cancer Of The Lung
  • Large Cell Neuroendocrine Tumors
  • Laryngeal Cancer Chemotherapy
  • Leukemia Genomics
  • Li Fraumeni Syndrome
  • Liquid Biopsy Testing
  • Liver Cancer Chemotherapy
  • Liver Cancer Genomics
  • Lobular Carcinoma In Situ (Lcis)
  • Long Term Side Effects Of Cancer Treatment
  • Lung Cancer
  • Lung Cancer Genomics
  • Lymphedema Therapy
  • Lymphoma
  • Lymphoma Genomics
  • Lymphoproliferative Disorder
  • Malignant Carcinoid Tumor Of Colon
  • Malignant Lung Tumors
  • Malignant Spindle Cell Neoplasm
  • Mediastinal Lymphadenopathy
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Metastatic Liver Cancer
  • Metastatic Rib Cancer
  • Microsatellite Stability
  • Monocytosis
  • Mouth Cancer Chemotherapy
  • Mucosal Melanoma
  • Multi-Cancer Early Detection Blood Test
  • Muscle Invasive Bladder Cancer
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Nasal Cavity Cancer Chemotherapy
  • Nasopharyngeal Cancer Chemotherapy
  • Neuronal Glial Tumors
  • Neurotrophic Tyrosine Receptor Kinase Gene Fusion
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Non Steroidal Aromatase Inhibitors
  • Non-Muscle Invasive Bladder Cancer
  • Octreotide Treatment
  • Onco Nephrology
  • Optic Nerve Glioma
  • Oral Complications Of Cancer
  • Oral Lesions
  • Orbit Cancer
  • Ovarian Cancer Chemotherapy
  • Ovarian Non Germ Cell Tumors
  • Palate Cancer
  • Pancreatic Cancer Chemotherapy
  • Pancreatic Cancer Genomics
  • Paraneoplastic Cerebellar Degeneration (Pcd)
  • Pediatric Cancer Research
  • Penile Cancer Chemotherapy
  • Personal History Of Chemotherapy
  • Personal History Of Radiation Therapy
  • Personalized Cancer Therapy
  • Plasma Cell Dyscrasia
  • Pleomorphic Xanthoastrocytomas
  • Pleural Cancer Chemotherapy
  • Post Radiation Pain
  • Primary Effusion Lymphoma
  • Primary Splenic Lymphoma
  • Prostate Cancer Chemotherapy
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rat Sarcoma Oncogenes Mutation
  • Rectal Cancer Genomics
  • Refractory Anemia With Excess Blasts
  • Refractory Cytopenia
  • Relapsed Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • Renal Cancer Genomics
  • Renal Cell Carcinoma Immunotherapy
  • Renal Pelvis Carcinoma
  • Renal Sarcoma
  • Retroperitoneal Mass
  • Rib Cancer
  • Salvage Cryotherapy
  • Salvage Prostatectomy
  • Sarcoma Genomics
  • Secondary Cancer Screening
  • Side Effects Of Cancer Treatment
  • Signet Ring Cell Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Skin Cancer Genomics
  • Skin Cancer Of The Ear
  • Skin Cancer Of The Face
  • Skin Cancer Of The Foot
  • Skin Cancer Of The Hand
  • Skin Cancer Of The Scalp
  • Skin Cancer On Penis
  • Small Cell Lung Cancer Chemotherapy
  • Small Intestine Cancer Chemotherapy
  • Smoldering Multiple Myeloma
  • Solid Tumors
  • Spine Mets
  • Spleen Cancer Chemotherapy
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma Of Bladder
  • Squamous Cell Carcinoma Of Penis
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Stomach Cancer Chemotherapy
  • Stomach Cancer Genomics
  • Stomatitis
  • Supratentorial Primitive Neuroectodermal Tumor
  • Systemic Therapy
  • T Cell Acute Lymphoblastic Leukemia
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Terminal Deoxynucleotidyl Transferase Expression
  • Testicular Cancer Chemotherapy
  • Theranostics
  • Thoracic Cancer
  • Throat Cancer Chemotherapy
  • Thyroid Cancer Genomics
  • Tongue Cancer Chemotherapy
  • Total Parenteral Nutrition (Tpn)
  • Tracheal Cancer
  • Tracheal Cancer Chemotherapy
  • Tumor Induced Osteomalacia
  • Unknown Primary Cancer
  • Uterine Cancer Chemotherapy
  • Vaginal Cancer Chemotherapy
  • Vaginal Melanoma
  • Vocal Cord Cancer
  • Vulvar Cancer Chemotherapy
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor 1 Mutations
  • Xanthogranuloma